Several multicenter clinical trials showed that GDF-15 can be regarded as a reliable biomarker of cardiovascular disease and chronic heart failure and is of independent prognostic value in predicting coronary artery disease (CAD), acute coronary syndromes (ACS) and heart failure (HF)9, 18, 19, 20, 21. This evidence concerns the gene GDF15 and cardiovascular disorder.